These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 23623999)
1. PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism. Peyrou M; Clément S; Maier C; Bourgoin L; Branche E; Conzelmann S; Kaddai V; Foti M; Negro F J Hepatol; 2013 Sep; 59(3):420-6. PubMed ID: 23623999 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets. Clément S; Peyrou M; Sanchez-Pareja A; Bourgoin L; Ramadori P; Suter D; Vinciguerra M; Guilloux K; Pascarella S; Rubbia-Brandt L; Negro F; Foti M Hepatology; 2011 Jul; 54(1):38-49. PubMed ID: 21465511 [TBL] [Abstract][Full Text] [Related]
3. Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein. Clément S; Sobolewski C; Gomes D; Rojas A; Goossens N; Conzelmann S; Calo N; Negro F; Foti M Liver Int; 2019 Jul; 39(7):1226-1236. PubMed ID: 30938910 [TBL] [Abstract][Full Text] [Related]
4. The role of PTEN - HCV core interaction in hepatitis C virus replication. Wu Q; Li Z; Mellor P; Zhou Y; Anderson DH; Liu Q Sci Rep; 2017 Jun; 7(1):3695. PubMed ID: 28623358 [TBL] [Abstract][Full Text] [Related]
5. Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production. Nourbakhsh M; Douglas DN; Pu CH; Lewis JT; Kawahara T; Lisboa LF; Wei E; Asthana S; Quiroga AD; Law LM; Chen C; Addison WR; Nelson R; Houghton M; Lehner R; Kneteman NM J Hepatol; 2013 Aug; 59(2):336-43. PubMed ID: 23542347 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein. Branche E; Conzelmann S; Parisot C; Bedert L; Lévy PL; Bartosch B; Clément S; Negro F PLoS One; 2016; 11(1):e0146000. PubMed ID: 26731658 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner. Gao TT; Qin ZL; Ren H; Zhao P; Qi ZT Virol J; 2015 Feb; 12():12. PubMed ID: 25645159 [TBL] [Abstract][Full Text] [Related]
9. Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication. Hofmann S; Krajewski M; Scherer C; Scholz V; Mordhorst V; Truschow P; Schöbel A; Reimer R; Schwudke D; Herker E Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1041-1056. PubMed ID: 29885363 [TBL] [Abstract][Full Text] [Related]
10. Treatment with PTEN-Long protein inhibits hepatitis C virus replication. Wu Q; Li Z; Liu Q Virology; 2017 Nov; 511():1-8. PubMed ID: 28783500 [TBL] [Abstract][Full Text] [Related]
11. HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on sphingolipid biosynthesis. Loizides-Mangold U; Clément S; Alfonso-Garcia A; Branche E; Conzelmann S; Parisot C; Potma EO; Riezman H; Negro F PLoS One; 2014; 9(12):e115309. PubMed ID: 25522003 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy. Del Campo JA; García-Valdecasas M; Gil-Gómez A; Rojas Á; Gallego P; Ampuero J; Gallego-Durán R; Pastor H; Grande L; Padillo FJ; Muntané J; Romero-Gómez M PLoS One; 2018; 13(1):e0191805. PubMed ID: 29385181 [TBL] [Abstract][Full Text] [Related]
13. FIG4 is a hepatitis C virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potential. Cottarel J; Plissonnier ML; Kullolli M; Pitteri S; Clément S; Millarte V; Si-Ahmed SN; Farhan H; Zoulim F; Parent R J Gen Virol; 2016 Jan; 97(1):69-81. PubMed ID: 26519381 [TBL] [Abstract][Full Text] [Related]
14. Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles. Hu L; Li J; Cai H; Yao W; Xiao J; Li YP; Qiu X; Xia H; Peng T Antiviral Res; 2017 Dec; 148():5-14. PubMed ID: 29074218 [TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. Sato S; Fukasawa M; Yamakawa Y; Natsume T; Suzuki T; Shoji I; Aizaki H; Miyamura T; Nishijima M J Biochem; 2006 May; 139(5):921-30. PubMed ID: 16751600 [TBL] [Abstract][Full Text] [Related]
16. Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus. Liefhebber JM; Hague CV; Zhang Q; Wakelam MJ; McLauchlan J J Biol Chem; 2014 Aug; 289(31):21276-88. PubMed ID: 24917668 [TBL] [Abstract][Full Text] [Related]
17. SUMO1 depletion prevents lipid droplet accumulation and HCV replication. Akil A; Wedeh G; Zahid Mustafa M; Gassama-Diagne A Arch Virol; 2016 Jan; 161(1):141-8. PubMed ID: 26449956 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus attenuates mitochondrial lipid β-oxidation by downregulating mitochondrial trifunctional-protein expression. Amako Y; Munakata T; Kohara M; Siddiqui A; Peers C; Harris M J Virol; 2015 Apr; 89(8):4092-101. PubMed ID: 25673715 [TBL] [Abstract][Full Text] [Related]
19. An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN. Wu Q; Li Z; Liu Q Virology; 2018 Jul; 520():94-102. PubMed ID: 29803738 [TBL] [Abstract][Full Text] [Related]
20. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis. Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]